Bharat Parenterals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 45.91 | 95.99 | 82.54 |
| Operating Expense | 39.36 | 79.11 | 75.70 |
| Net Profit | 2.73 | 10 | 2.28 |
| Net Profit Margin | 5.95 | 10.42 | 2.76 |
| Earning Per Share | 3.96 | 14.51 | 3.48 |
| EBIDTA | 7 | 17.18 | 6.91 |
| Effective Tax Rate | 17.40 | 21.92 | 19.44 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 45.91 |
| Operating Expense | 39.36 |
| Net Profit | 2.73 |
| Net Profit Margin | 5.95 |
| Earning Per Share | 3.96 |
| EBIDTA | 7.00 |
| Effective Tax Rate | 17.40 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 304.13 | 257.98 | 217.98 |
| Operating Expenses Annual | 270.53 | 225.03 | 196.62 |
| Operating Profit Annual | 48.15 | 41.00 | 40.20 |
| Interest Annual | 4.79 | 3.80 | 2.19 |
| Depreciation | 7.05 | 6.40 | 5.85 |
| Net Profit Annual | 26.45 | 22.59 | 24.34 |
| Tax Annual | 9.86 | 8.21 | 7.83 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 304.13 |
| Operating Expenses Annual | 270.53 |
| Operating Profit Annual | 48.15 |
| Interest Annual | 4.79 |
| Depreciation | 7.05 |
| Net Profit Annual | 26.45 |
| Tax Annual | 9.86 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.43 | 6.34 | 3.33 |
| Cash Flow from Operations | 19.22 | -0.16 | -11.56 |
| Cash Flow from Investing | -89.69 | -38.19 | -13.95 |
| Cash Flow from Financing | 69.25 | 33.51 | 28.52 |
| Cash Flow at the End | 0.22 | 1.50 | 6.34 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1.43 |
| Cash Flow from Operations | 19.22 |
| Cash Flow from Investing | -89.69 |
| Cash Flow from Financing | 69.25 |
| Cash Flow at the End | 0.22 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 15.84 | 14.52 | 13.62 |
| PBIT Margin (%) | 13.52 | 12.26 | 11.31 |
| PBT Margin (%) | 10.70 | 9.14 | 6.91 |
| Net PROFIT Margin (%) | 8.70 | 7.98 | 9.63 |
| Return On Networth / Equity (%) | 8.81 | 11.16 | 11.08 |
| Return On Networth /Employed (%) | 10.88 | 12.94 | 13.60 |
| Return On Assets (%) | 6.96 | 8.45 | 11.56 |
| Total Debt / Equity (X) | 0.24 | 0.32 | 0.17 |
| Asset Turnover Ratio (%) | 0.80 | 1.06 | 1.20 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 15.84 |
| PBIT Margin (%) | 13.52 |
| PBT Margin (%) | 10.70 |
| Net PROFIT Margin (%) | 8.70 |
| Return On Networth / Equity (%) | 8.81 |
| Return On Networth /Employed (%) | 10.88 |
| Return On Assets (%) | 6.96 |
| Total Debt / Equity (X) | 0.24 |
| Asset Turnover Ratio (%) | 0.80 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 45.37 | 38.47 | 35.28 |
| Total Current Assets Annual | 265.78 | 220.31 | 174.51 |
| Non Current Assets Annual | 283.41 | 166.84 | 133.51 |
| Total Shareholders Funds Annual | 386.83 | 213.61 | 191.06 |
| Total Assets Annual | 549.19 | 387.15 | 308.03 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 45.37 |
| Total Current Assets Annual | 265.78 |
| Non Current Assets Annual | 283.41 |
| Total Shareholders Funds Annual | 386.83 |
| Total Assets Annual | 549.19 |
EPS (INR)
Expected
-10.51
Reported
-14.00
Surprise
33.21%
Jun 2025
EPS beaten by 33.21%
Mar 2025
EPS beaten by -108.38%
Dec 2024
EPS beaten by 109.61%
